Published in Gastroenterol Res Pract on March 03, 2015
A prospective view of animal and human Fasciolosis. Parasite Immunol (2016) 0.77
Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol (2016) 0.76
Liver Flukes and the Microbiota in Cancer. EBioMedicine (2016) 0.76
The Crosstalk between the Gut Microbiota and Mitochondria during Exercise. Front Physiol (2017) 0.76
Diversity of the human intestinal microbial flora. Science (2005) 49.64
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest (2002) 21.08
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell (2000) 7.18
Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A (2010) 7.09
Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94
Bile salt biotransformations by human intestinal bacteria. J Lipid Res (2005) 6.00
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol (2000) 5.72
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol (2005) 5.62
Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65
The role of psychological and biological factors in postinfective gut dysfunction. Gut (1999) 4.54
The interaction between bacteria and bile. FEMS Microbiol Rev (2005) 3.86
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A (2006) 3.05
Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82
Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res (2005) 2.64
Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A (2008) 2.53
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2001) 2.38
Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med (1981) 2.17
Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol (2010) 2.02
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol (2000) 2.00
Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev (2007) 1.94
Abnormal colonic fermentation in irritable bowel syndrome. Lancet (1998) 1.91
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem (2004) 1.90
Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol (2009) 1.88
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol (2009) 1.87
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun (2008) 1.83
Regulation of homeostasis and inflammation in the intestine. Gastroenterology (2011) 1.82
Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol (2005) 1.67
Bile acid induction specificity of 7 alpha-dehydroxylase activity in an intestinal Eubacterium species. Steroids (1980) 1.45
Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol (2004) 1.42
The fecal microbial population in the irritable bowel syndrome. Microbiologica (1982) 1.40
The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care (2008) 1.31
Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol (2010) 1.29
7alpha-Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res (1979) 1.26
Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil (2012) 1.25
Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil (2013) 1.13
Bile acids: from digestion to cancers. Biochimie (2012) 1.08
Bile salts and cholesterol induce changes in the lipid cell membrane of Lactobacillus reuteri. J Appl Microbiol (2003) 1.08
A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol (2012) 1.08
Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum. J Dairy Sci (1998) 1.06
A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 1.06
Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J Biol Chem (1990) 1.05
Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes (2012) 1.01
Postinfectious irritable bowel syndrome. Clin Infect Dis (2008) 1.01
Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel) (2013) 1.00
Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens (2013) 0.97
Review article: next generation diagnostic modalities in gastroenterology--gas phase volatile compound biomarker detection. Aliment Pharmacol Ther (2014) 0.97
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) (2014) 0.90
Dynamic interactions between bacteria and immune cells leading to intestinal IgA synthesis. Semin Immunol (2008) 0.89
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. J Dig Dis (2009) 0.88
Minimal Gluten Exposure Alters Urinary Volatile Organic Compounds in Stable Coeliac Disease. Sensors (Basel) (2022) 0.75
Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results. J Gastrointestin Liver Dis (2015) 0.75